Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics
暂无分享,去创建一个
Michael Schenk | Markus Wenzel | Ivayla Apostolova | Susanne Klutmann | Catharina Lange | Ralph Buchert | Fausto Milletari | Julia Krüger | Marcus Ehrenburg | Markus T. Wenzel | I. Apostolova | R. Buchert | S. Klutmann | C. Lange | J. Krüger | Michael Schenk | F. Milletarì | Marcus Ehrenburg
[1] Dong Young Lee,et al. Adaptive template generation for amyloid PET using a deep learning approach , 2018, Human brain mapping.
[2] Jan Booij,et al. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.
[3] Kota Yokoyama,et al. Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[4] John Seibyl,et al. SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* , 2012, The Journal of Nuclear Medicine.
[5] Mona Mustafa,et al. Influence of movement on FP-CIT SPECT quantification: a Monte Carlo based simulation , 2007, Nuclear medicine communications.
[6] Richard G. Baraniuk,et al. A Probabilistic Framework for Deep Learning , 2016, NIPS.
[7] Dinggang Shen,et al. Deep auto-context convolutional neural networks for standard-dose PET image estimation from low-dose PET/MRI , 2017, Neurocomputing.
[8] Peter Bartenstein,et al. Radius dependence of FP-CIT quantification: a Monte Carlo-based simulation study , 2014, Annals of Nuclear Medicine.
[9] Ayman El-Baz,et al. Alzheimer's disease diagnostics by adaptation of 3D convolutional network , 2016, 2016 IEEE International Conference on Image Processing (ICIP).
[10] Francisco Jesús Martínez-Murcia,et al. Convolutional Neural Networks for Neuroimaging in Parkinson's Disease: Is Preprocessing Needed? , 2018, Int. J. Neural Syst..
[11] Joaquim Salvi,et al. One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks , 2018, NeuroImage: Clinical.
[12] Francisco Jesús Martínez-Murcia,et al. Using deep neural networks along with dimensionality reduction techniques to assist the diagnosis of neurodegenerative disorders , 2018, Log. J. IGPL.
[13] Mirza Faisal Beg,et al. Multiscale deep neural network based analysis of FDG‐PET images for the early diagnosis of Alzheimer's disease , 2018, Medical Image Anal..
[14] A. McMillan,et al. Deep learning Mr imaging–based attenuation correction for PeT/Mr imaging 1 , 2017 .
[15] Seunggyun Ha,et al. Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging , 2017, NeuroImage: Clinical.
[16] Yiming Ding,et al. A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain. , 2019, Radiology.
[17] Dinggang Shen,et al. 3D conditional generative adversarial networks for high-quality PET image estimation at low dose , 2018, NeuroImage.
[18] H Amthauer,et al. Global scaling for semi-quantitative analysis in FP-CIT SPECT , 2014, Nuklearmedizin.
[19] João Manuel R S Tavares,et al. Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[20] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.
[21] Kyong Hwan Jin,et al. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging , 2017, Behavioural Brain Research.
[22] A. Singleton,et al. The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.
[23] J. Darcourt,et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[24] Dinggang Shen,et al. Deep Learning Based Imaging Data Completion for Improved Brain Disease Diagnosis , 2014, MICCAI.
[25] Claus Svarer,et al. Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[26] K. Tatsch,et al. Quantitative approaches to dopaminergic brain imaging. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[27] Dinggang Shen,et al. Effective feature learning and fusion of multimodality data using stage‐wise deep neural network for dementia diagnosis , 2018, Human brain mapping.
[28] John O. Prior,et al. Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study , 2018, PloS one.
[29] K. Laere,et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[30] Koen Van Laere,et al. The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging , 2017, EJNMMI Research.
[31] Osama Sabri,et al. Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-β-Carbomethoxy-3β-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies , 2013, The Journal of Nuclear Medicine.
[32] Nico Karssemeijer,et al. Transfer Learning for Domain Adaptation in MRI: Application in Brain Lesion Segmentation , 2017, MICCAI.
[33] Wouter M. Kouw,et al. MR Acquisition-Invariant Representation Learning , 2017, ArXiv.
[34] Danni Cheng,et al. Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images , 2018, Front. Neuroinform..
[35] Jacques Darcourt,et al. Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[36] N. De Stefano,et al. Clinical use of brain volumetry , 2013, Journal of magnetic resonance imaging : JMRI.
[37] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[38] Jacques Darcourt,et al. Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[39] Michael S. Bernstein,et al. ImageNet Large Scale Visual Recognition Challenge , 2014, International Journal of Computer Vision.
[40] Koen Van Laere,et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[41] Zuzana Walker,et al. Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials , 2014, BMJ Open.
[42] Nikolaos Karatzas,et al. SPECT imaging evaluation in movement disorders: far beyond visual assessment , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[43] Markus Nowak Lonsdale,et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[44] Osama Sabri,et al. Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] Sergey Ioffe,et al. Rethinking the Inception Architecture for Computer Vision , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[46] Michel Koole,et al. [123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods , 2017, EJNMMI Physics.
[47] Wim Vandenberghe,et al. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[48] Bram van Ginneken,et al. A survey on deep learning in medical image analysis , 2017, Medical Image Anal..
[49] Kenji Hirata,et al. Convolutional neural network can help differentiate FDG PET images of brain tumor between glioblastoma and primary central nervous system lymphoma , 2016 .
[50] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[51] Paras Lakhani,et al. Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia , 2017, The Journal of Nuclear Medicine.
[52] Jeffrey A. Fessler,et al. Reducing between scanner differences in multi-center PET studies , 2009, NeuroImage.
[53] Shihui Ying,et al. Multimodal Neuroimaging Feature Learning With Multimodal Stacked Deep Polynomial Networks for Diagnosis of Alzheimer's Disease , 2018, IEEE Journal of Biomedical and Health Informatics.
[54] Jens Kurth,et al. CT-Based Attenuation Correction in I-123-Ioflupane SPECT , 2014, PloS one.
[55] Robert B. Innis,et al. Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[56] M. Thurston,et al. Artificial intelligence in the diagnosis of Parkinson’s disease from ioflupane-123 single-photon emission computed tomography dopamine transporter scans using transfer learning , 2018, Nuclear medicine communications.
[57] Jacques Darcourt,et al. Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using 123I-Ioflupane Injection (DaTscan) Imaging , 2014, The Journal of Nuclear Medicine.
[58] Klaus Tatsch,et al. Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update , 2013, The Journal of Nuclear Medicine.
[59] Anders M. Dale,et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.